Mini review · 13 Apr 2026
Conference abstractPublished 28 Oct 2016
Fructooligosacchairde (Fos) can modulate gut satietogenic hormones, gut flora and induce weight loss in obese adults
Maharaja Sayajirao University of Baroda, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In India, the era of health transition has brought the dual burden of under and over-nutrition. Recent researches focuses on identifying unconventional mechanisms of obesity involving gut - brain axis, prevention and treatment of obesity. Hence this study was conducted with an objective to examine the effects of Fructooligosaccharide (FOS) supplementation on gut satietogenic hormones (GLP-1, GIP, PYY, Leptin, Ghrelin and Insulin), gut-flora (Bifidobacterium, Lactobacillus, Clostridium and Bacteroides), and anthropometric measurements. A randomized, double-blind, placebo controlled trial with 120 young obese grade âÂ?Â?I subjects (25-35 yrs) was designed. They were randomly assigned to groups that received either 20g FOS/d or 20g dextrose/d for 90 days. Anthropometric measurements, fasting plasma and faecal samples were collected at baseline and post intervention. Plasma samples for gut hormones were analyzed using Luminex x-MAP technology in sub sample of 60 subjects. Results in experimental group revealed significant reduction in weight, BMI, WC, WHR and body fat by 2.55%, 2.45%, 2.51%, 3.11%, and 5.93% respectively as compared to placebo group. Colonization of (8.13%) and Lactobacillus (10.77%) was significantly increased, however significant reduction in colonization of Clostridium (1.87%) and Bacteroides (13.07%) was observed. Significant increase in plasma level of gut satietogenic hormone GLP-1 (1.53%) and Ghrelin (17.33%) along-with reduction in Leptin (5.78%) and Insulin (5.83%) was also observed. Weight negatively correlated (p<0.001) with GLP-1(r = -0.729) and GIP (r = -0.603) and positively with Clostridium (r = 0.09, NS) and Bacteroides (r = 0.09, NS). Stepwise linear regression depicted GLP-1 as a strong predictor of obesity (58.6%). Hence, FOS proves to be a promising supplement in inducing weight loss by modulating gut satietogenic hormones and gutflora.
Subjects
Obesity & Weight ManagementAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Obesity & Weight Loss Therapy.
Research article · 27 Feb 2026
Modulation of Postprandial GLP-1 Secretion and Glycemic Responses by a Food-Grade GLP-1 Formula in Human Subjects
Short communication · 9 Feb 2026
Intensive Blood Pressure Lowering Target Guided by Home Blood Pressure Monitoring for Hypertensive Patients with Type 2 Diabetes, Which is Better or Not
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Obesity & Weight Loss Therapy
- SubjectObesity & Weight Management
- BylineArticles whose byline prints “Aparna Assudani”
- BylineArticles whose byline prints “Mini Sheth”